mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for TDG
Gene summary
Basic gene Info.Gene symbolTDG
Gene namethymine-DNA glycosylase
SynonymshTDG
CytomapUCSC genome browser: 12q24.1
Type of geneprotein-coding
RefGenesNM_003211.4,
NM_001008411.1,
DescriptionG/T mismatch-specific thymine DNA glycosylase
Modification date20141222
dbXrefs MIM : 601423
HGNC : HGNC
Ensembl : ENSG00000139372
HPRD : 03251
Vega : OTTHUMG00000168418
ProteinUniProt: Q13569
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_TDG
BioGPS: 6996
PathwayNCI Pathway Interaction Database: TDG
KEGG: TDG
REACTOME: TDG
Pathway Commons: TDG
ContextiHOP: TDG
ligand binding site mutation search in PubMed: TDG
UCL Cancer Institute: TDG
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006284base-excision repair21862836
GO:0006298mismatch repair22573813


Top
Ligand binding site mutations for TDG
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
K201K201TCOAD1
S273S273RGBM1
F252F252IGBM1
K201K201TKIRC1
S273S273ILUAD1
R275R275ILUAD1
D202D202YOV1
N230F229SUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for TDG
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
S273S273I0.21967836
S273S273R0.070070195
K201K201T0.051207937
R275R275I-0.81436879
N230F229S-0.7040596
F252F252I-0.45066146
D202D202Y-0.38750937
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for TDG from PDB

Top
Differential gene expression and gene-gene network for TDG
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of TDG and the right PPI network was created from samples without mutations in the LBS of TDG. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for TDG
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for TDG
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of TDG go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NUCNucleic Acids3uobAF252 S273 R275
NUCNucleic Acids4jgcAF252 S273 R275
NUCNucleic Acids4z7zAF252 S273 R275
NUCNucleic Acids5cysAF252 S273 R275
NUCNucleic Acids3uo7BK201
NUCNucleic Acids3ufjAK201 D202 R275
NUCNucleic Acids3uobBK201 F252 S273
NUCNucleic Acids4fncAK201 F252 S273 R275
NUCNucleic Acids4xegAK201 F252 S273 R275
NUCNucleic Acids4z47AK201 F252 S273 R275
NUCNucleic Acids3ufjBK201 R275
NUCNucleic Acids4fncAK201 R275
NUCNucleic Acids4z3aAK201 R275
NUCNucleic Acids3uo7AK201 S273 R275
NUCNucleic Acids4z3aAK201 S273 R275
NUCNucleic Acids4z7bAK201 S273 R275
HMU5-HYDROXYMETHYLURACIL4fncAN230
1RT4-AMINO-2-OXO-1,2-DIHYDROPYRIMIDINE-5-CARBOXYLIC ACID4jgcAN230
NUCNucleic Acids2rbaBR275
NUCNucleic Acids2rbaBR275
NUCNucleic Acids3ufjAR275
NUCNucleic Acids3ufjBR275
NUCNucleic Acids4jgcAR275
NUCNucleic Acids4xegAR275
NUCNucleic Acids4z47AR275
NUCNucleic Acids4z7bAR275
NUCNucleic Acids4z7zAR275
NUCNucleic Acids5cysAR275
NUCNucleic Acids2rbaAS273 R275
NUCNucleic Acids3ufjAS273 R275
NUCNucleic Acids3ufjBS273 R275


Top
Conservation information for LBS of TDG
Multiple alignments for Q13569 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas